Amicus Therapeutics appoints VP, regulatory strategy
Dr. Mulberg is a pediatric gastroenterologist who has spent the past 6 years working at the U.S. Food and Drug Administration (FDA), most recently as Deputy Director of the Division of Gastroenterology and Inborn Errors Products. Dr. Mulberg will serve as a member of the executive team.
In addition to Dr. Mulberg's FDA experience, he previously held various roles of increasing responsibility within global drug development and medical affairs at leading pharmaceutical companies, including Johnson & Johnson, where he successfully led multiple products through clinical development to regulatory approvals.
Dr. Mulberg received his B.A. from Columbia University and his M.D. from the Mount Sinai School of Medicine. From 1993-2010, he served as Attending Physician in Gastroenterology and Hepatology at Children's Hospital of Philadelphia.
He currently serves as Adjunct Professor of Pediatrics at the University of Maryland School of Medicine, Adjunct Associate Professor of Pediatrics in the University of Pennsylvania School of Medicine and Associate Professor of Pharmacy at the University of the Sciences in Philadelphia.
Dr. Mulberg is also a member of numerous medical organizations including Alpha Omega Alpha Honor Medical Society, American Gastroenterological Association and the North American Society for Pediatric Gastroenterology and Nutrition. ■
What to read next
LATEST MOVES FROM New Jersey
- Wireless Telecom Group appoints Daniel Monopoli as CTO
- New Jersey Resources names Maureen Borkowski to board
- Milestone Scientific appoints Daniel Goldberger as CEO
- Celldex changes management team
- Pacira Pharmaceuticals appoints Mark I. Froimson to board
More inside POST
Virgin America computer systems hacked Companies
Bed Bath & Beyond to cut 880 jobs Companies
How to be 'The one for the top' Leadership